Cannabis Europa conference London program brochure, mei 2018

‘The science around medical cannabis has long been controversial and disputed, due in large part to existing regulations that have made the study of the cannabis plant extremely difficult. As a result, funding has traditionally been in short supply for scientists wanting to study cannabis’ therapeutic and medical potential. All of this is now changing as the evidence becomes undeniable, and countries move to legislate.’

Cannabis Europa conference London program brochure, mei 2018